Osteoporosis International

, Volume 22, Issue 10, pp 2611–2621 | Cite as

Prevalence and costs of osteoporotic patients with subsequent non-vertebral fractures in the US

  • C. T. Pike
  • H. G. Birnbaum
  • M. Schiller
  • E. Swallow
  • R. T. Burge
  • E. T. Edgell
Original Article

Abstract

Summary

This study assesses prevalence of subsequent fractures during the year after incident osteoporosis-related non-vertebral fractures among privately insured and Medicare populations and compares costs between patients with and without subsequent fractures. Many non-vertebral fracture patients incur subsequent fractures, and those who do are significantly more costly during the year after incident fracture.

Introduction

To estimate the prevalence of subsequent osteoporosis-related non-vertebral (NV) fractures during the year following an incident NV fracture and compare costs between NV fracture patients with and without subsequent fractures.

Methods

Using insurance claims data (1999–2006), privately-insured (ages 18–64 years) and Medicare (ages 65+ years) patients with ≥1 subsequent osteoporosis-related NV fracture within a year of an incident osteoporosis-related NV fracture were matched to controls with incident NV fractures but no subsequent fractures. Subsequent fractures were identified as any claim for an NV fracture occurring >3 months after the incident NV fracture (>6 months were required for fractures occurring at the same site as the incident fracture). The study assessed prevalence of subsequent fractures and compared costs (from the payer’s perspective) between patients with and without subsequent fractures over the year following an incident NV fracture.

Results

Among privately insured NV fracture patients, 14.1% had any subsequent NV fractures, 1.6% had subsequent hip fractures, and 13.0% had subsequent non-vertebral, non-hip (NVNH) fractures, while 22.6% of Medicare NV fracture patients had subsequent NV fractures, 9.4% had subsequent hip fractures, and 15.5% had subsequent NVNH fractures. Mean excess health care costs per privately insured subsequent fracture patient were $9,789 ($19,072 vs. $9,914, p < 0.01), while excess medical costs per Medicare subsequent fracture patient were $12,527 ($31,904 vs. $19,377, p < 0.01).

Conclusions

NV fracture patients are at substantial risk for subsequent NV fractures within 1 year, and patients who incur subsequent fractures are significantly more costly than those who do not during the year following an incident fracture.

Keywords

Epidemiology Fractures Health services and economics Osteoporosis Population studies 

References

  1. 1.
    Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 22(3):465–475PubMedCrossRefGoogle Scholar
  2. 2.
    National Osteoporosis Foundation: Fast Facts on Osteoporosis. http://www.nof.org/osteoporosis/diseasefacts.htm (Accessed 13 August 2009)
  3. 3.
    Pasco JA, Sanders KM, Hoekstra FM, Henry MJ, Nicholson GC, Kotowicz MA (2005) The human cost of fracture. Osteoporos Int 16(12):2046–2052PubMedCrossRefGoogle Scholar
  4. 4.
    Boonen S, Autier P, Barette M, Vanderschueren D, Lips P, Haentjens P (2004) Functional outcome and quality of life following hip fracture in elderly women: a prospective controlled study. Osteoporos Int 15(2):87–94PubMedCrossRefGoogle Scholar
  5. 5.
    Tosteson AN, Gabriel SE, Grove MR, Moncur MM, Kneeland TS, Melton LJ 3rd (2001) Impact of hip and vertebral fractures on quality-adjusted life years. Osteoporos Int 12(12):1042–1049PubMedCrossRefGoogle Scholar
  6. 6.
    Oglesby AK, Minshall ME, Shen W, Xie S, Silverman SL (2003) The impact of incident vertebral and non-vertebral fragility fractures on health-related quality of life in established postmenopausal osteoporosis: results from the teriparatide randomized, placebo-controlled trial in postmenopausal women. J Rheaumatol 30(7):1579–1583Google Scholar
  7. 7.
    Orsini LS, Rousculp MD, Long SR, Wang S (2005) Health care utilization and expenditures in the United States: a study of osteoporosis related fractures. Osteoporos Int 16(4):359–371PubMedCrossRefGoogle Scholar
  8. 8.
    Ohsfeldt RL, Borisov NN, Sheer RL (2006) Fragility fracture-related direct medical costs in the first year following a nonvertebral fracture in a managed care setting. Osteoporos Int 17(2):252–258PubMedCrossRefGoogle Scholar
  9. 9.
    Lindsay R, Burge RT, Strauss DM (2005) One year outcomes and costs following a vertebral fracture. Osteoporos Int 16(1):78–85PubMedCrossRefGoogle Scholar
  10. 10.
    Rousculp MD, Long SR, Wang S, Schoenfeld MJ, Meadows ES (2007) Economic burden of osteoporosis-related fractures in Medicaid. Value Health 10(2):144–152PubMedCrossRefGoogle Scholar
  11. 11.
    Cauley JA, Thompson DE, Ensrud KC, Scott JC, Black D (2000) Risk of mortality following clinical fractures. Osteoporos Int 11(7):556–561PubMedCrossRefGoogle Scholar
  12. 12.
    Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA (1999) Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 353(9156):878–882PubMedCrossRefGoogle Scholar
  13. 13.
    Richmond J, Aharonoff GB, Zuckerman JD, Koval KJ (2003) Mortality risk after hip fracture. J Orthop Trauma 17(1):53–56PubMedCrossRefGoogle Scholar
  14. 14.
    Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301(5):513–521PubMedCrossRefGoogle Scholar
  15. 15.
    Melton LJ 3rd, Atkinson EJ, Cooper C, O’Fallon WM, Riggs BL (1999) Vertebral fractures predict subsequent fractures. Osteoporos Int 10(3):214–221PubMedCrossRefGoogle Scholar
  16. 16.
    Cuddihy MT, Gabriel SE, Crowson CS, O’Fallon WM, Melton LJ 3rd (1999) Forearm fractures as predictors of subsequent osteoporotic fractures. Osteoporos Int 9(6):469–475PubMedGoogle Scholar
  17. 17.
    Kanis JA, Johnell O, De Laet C, Johansson H, Oden A, Delmas P, Eisman J, Fujiwara S, Garnero P, Kroger H, McCloskey EV, Mellstrom D, Melton LJ 3rd, Pols H, Reeve J, Silman A, Tenenhouse A (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35(2):375–382PubMedCrossRefGoogle Scholar
  18. 18.
    Hodsman AB, Leslie WD, Tsang JF, Gamble GD (2008) 10-year probability of recurrent fractures following wrist and other osteoporotic fractures in a large clinical cohort: an analysis from the Manitoba Bone Density Program. Arch Intern Med 168(20):2261–2267PubMedCrossRefGoogle Scholar
  19. 19.
    Lyles KW, Schenck AP, Colon-Emeric CS (2008) Hip and other osteoporotic fractures increase the risk of subsequent fractures in nursing home residents. Osteoporos Int 19(8):1225–1233PubMedCrossRefGoogle Scholar
  20. 20.
    Robinson CM, Royds M, Abraham A, McQueen MM, Court-Brown CM, Christie J (2002) Refractures in patient at least forty-five years old: a prospective analysis of twenty-two thousand and sixty patients. J Bone Jt Surg Am 84(9):1528–1533Google Scholar
  21. 21.
    Van Staa TP, Leufkens HGM, Cooper C (2002) Does a fracture at one site predict later fracture at other sites? A British cohort study. Osteoporos Int 13(8):624–629PubMedCrossRefGoogle Scholar
  22. 22.
    Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA 3rd, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15(4):721–739PubMedCrossRefGoogle Scholar
  23. 23.
    Melton LJ 3rd, Gabriel SE, Crowson CS, Tosteson AN, Johnell O, Kanis JA (2003) Cost-equivalence of different osteoporotic fractures. Osteoporos Int 14:383–388PubMedCrossRefGoogle Scholar
  24. 24.
    Ray NF, Chan JK, Thamer M, Melton LJ 3rd (1997) Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 12(1):24–35PubMedCrossRefGoogle Scholar
  25. 25.
    Melton LJ 3rd (2003) Adverse outcomes of osteoporotic fractures in the general population. J Bone Miner Res 18(6):1139–1141PubMedCrossRefGoogle Scholar
  26. 26.
    Pike C, Birnbaum HG, Schiller M, Sharma H, Burge R, Edgell ET (2010) Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US. Pharmacoeconomics 28(5):1–15CrossRefGoogle Scholar
  27. 27.
    Boonen S, Singer AJ (2008) Osteoporosis management: impact of fracture type on cost and quality of life in patients at risk for fracture I. Curr Med Res Opin 24(6):1781–1788PubMedCrossRefGoogle Scholar
  28. 28.
    Martin BC, Chisholm MA, Kotzan JA (2001) Isolating the costs of osteoporosis-related fracture for postmenopausal women. Gerontology 47(1):21–29PubMedCrossRefGoogle Scholar
  29. 29.
    Siris ES, Miller PD, Barrett-Connor E, Faulkner KG, Wehren LE, Abbott TA, Berger ML, Santora AC, Sherwood LM (2001) Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA 286(22):2815–2822PubMedCrossRefGoogle Scholar
  30. 30.
    Eastell R, Adams JE, Coleman RE, Howell A, Hannon RA, Cuzick J, Mackey JR, Beckmann MW, Clack G (2008) Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trail 18233230. J Clin Oncol 26(7):1051–1057PubMedCrossRefGoogle Scholar
  31. 31.
    Blouin S, Libouban H, Moreau MF, Chappard D (2008) Orchidectomy models of osteoporosis. Methods Mol Biol 455:125–134PubMedCrossRefGoogle Scholar
  32. 32.
    Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383PubMedCrossRefGoogle Scholar
  33. 33.
    Romano PS, Roos LL, Jollis J (1993) Adapting a clinical comorbidity index for use with ICD-9-CM administrative data. J Clin Epidemiol 46(10):1075–1079PubMedCrossRefGoogle Scholar
  34. 34.
    U.S. Medical Care (CUUR0000SAM). Consumer Price Index—All Urban Consumers. Bureau of Labor Statistics. http://www.bls.gov/data/ (Accessed 7 September 2009)
  35. 35.
    Papaioannou A, Kennedy C, Ioannidis G, Gao Y, Sawka AM, Goltzman D, Tenenhouse A, Pickard L, Olszynski WP, Davison KS, Kaiser S, Josse RG, Kreiger N, Hanley DA, Prior JC, Brown JP, Anastassiades T, Adachi JD, CaMos Research Group (2008) The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study. Osteoporos Int 19(4):581–587PubMedCrossRefGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2010

Authors and Affiliations

  • C. T. Pike
    • 1
  • H. G. Birnbaum
    • 1
  • M. Schiller
    • 1
  • E. Swallow
    • 1
  • R. T. Burge
    • 2
    • 3
  • E. T. Edgell
    • 2
  1. 1.Analysis Group, Inc.BostonUSA
  2. 2.Eli Lilly and Company, Lilly Corporate CenterIndianapolisUSA
  3. 3.University of CincinnatiCincinnatiUSA

Personalised recommendations